MAP3K2
Basic information
Region (hg38): 2:127298668-127388465
Previous symbols: [ "MEKK2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MAP3K2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 17 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 17 | 0 | 2 |
Variants in MAP3K2
This is a list of pathogenic ClinVar variants found in the MAP3K2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-127307620-C-T | not specified | Uncertain significance (Sep 27, 2021) | ||
2-127307653-G-A | not specified | Uncertain significance (May 02, 2024) | ||
2-127307674-A-G | not specified | Uncertain significance (Oct 12, 2022) | ||
2-127307698-T-C | not specified | Uncertain significance (Dec 04, 2024) | ||
2-127307740-T-C | MAP3K2-related condition | Uncertain significance (Jun 27, 2024) | ||
2-127308589-T-C | not specified | Uncertain significance (Jan 04, 2024) | ||
2-127308665-C-G | not specified | Uncertain significance (Jul 25, 2023) | ||
2-127308684-C-G | not specified | Uncertain significance (Nov 18, 2022) | ||
2-127308687-A-C | not specified | Uncertain significance (May 30, 2024) | ||
2-127308760-C-T | not specified | Uncertain significance (Mar 06, 2023) | ||
2-127314883-C-T | not specified | Uncertain significance (Oct 29, 2021) | ||
2-127317648-A-T | not specified | Uncertain significance (Dec 20, 2023) | ||
2-127317689-A-G | Benign (Jul 17, 2018) | |||
2-127318189-C-T | not specified | Uncertain significance (Mar 14, 2023) | ||
2-127318240-C-T | not specified | Uncertain significance (Apr 11, 2023) | ||
2-127318251-T-C | not specified | Uncertain significance (Aug 02, 2021) | ||
2-127322108-C-T | not specified | Uncertain significance (Jul 08, 2024) | ||
2-127322212-G-T | Benign (Mar 29, 2018) | |||
2-127322234-C-A | not specified | Uncertain significance (Mar 07, 2024) | ||
2-127326727-A-T | not specified | Uncertain significance (Dec 08, 2021) | ||
2-127326751-G-A | not specified | Uncertain significance (May 20, 2024) | ||
2-127329962-G-C | not specified | Uncertain significance (Oct 20, 2024) | ||
2-127329996-C-T | not specified | Uncertain significance (Aug 28, 2024) | ||
2-127329999-A-T | not specified | Uncertain significance (Jul 06, 2021) | ||
2-127330412-C-A | not specified | Uncertain significance (Apr 12, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MAP3K2 | protein_coding | protein_coding | ENST00000409947 | 16 | 89736 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000820 | 124638 | 0 | 3 | 124641 | 0.0000120 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.31 | 198 | 313 | 0.633 | 0.0000159 | 4011 |
Missense in Polyphen | 67 | 134.69 | 0.49744 | 1720 | ||
Synonymous | 0.190 | 104 | 106 | 0.977 | 0.00000518 | 1137 |
Loss of Function | 5.31 | 0 | 32.9 | 0.00 | 0.00000188 | 436 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000288 | 0.0000265 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7 (By similarity). Plays a role in caveolae kiss-and-run dynamics. {ECO:0000250, ECO:0000269|PubMed:10713157, ECO:0000269|PubMed:16001074}.;
- Pathway
- GnRH signaling pathway - Homo sapiens (human);Gap junction - Homo sapiens (human);MAPK signaling pathway - Homo sapiens (human);EGF-Core;IL-1 signaling pathway;Brain-Derived Neurotrophic Factor (BDNF) signaling pathway;MAPK Signaling Pathway;Angiopoietin Like Protein 8 Regulatory Pathway;MAPK Cascade;EGF-EGFR Signaling Pathway;Insulin Signaling;mapkinase signaling pathway;IL1;IL-7 signaling;EGFR1;ErbB1 downstream signaling;JAK STAT pathway and regulation;EPO signaling;TNFalpha;VEGF;Trk receptor signaling mediated by the MAPK pathway
(Consensus)
Recessive Scores
- pRec
- 0.170
Intolerance Scores
- loftool
- rvis_EVS
- -0.29
- rvis_percentile_EVS
- 33.2
Haploinsufficiency Scores
- pHI
- 0.612
- hipred
- Y
- hipred_score
- 0.786
- ghis
- 0.597
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.941
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Map3k2
- Phenotype
- homeostasis/metabolism phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- activation of MAPKK activity;activation of MAPK activity;protein phosphorylation;activation of JUN kinase activity;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;positive regulation of transcription, DNA-templated;cellular response to mechanical stimulus
- Cellular component
- nucleoplasm;cytoplasm;cytosol
- Molecular function
- protein kinase activity;protein serine/threonine kinase activity;MAP kinase kinase kinase activity;protein binding;ATP binding;protein kinase binding;metal ion binding